Deborah Carosella - Jun 1, 2022 Form 4 Insider Report for Arcadia Biosciences, Inc. (RKDA)

Role
Director
Signature
Deborah D. Carosella, by Attorney-in-Fact, Cesare Suardi
Stock symbol
RKDA
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 12:49 PM
Previous filing
Jun 2, 2022
Next filing
Jun 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RKDA Stock Option (right to buy) Award $0 +23.6K +72.04% $0.00 56.4K Jun 1, 2022 Common Stock 23.6K $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service.